Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate

被引:0
作者
Tom H. Peeters
Krissie Lenting
Vincent Breukels
Sanne A. M. van Lith
Corina N. A. M. van den Heuvel
Remco Molenaar
Arno van Rooij
Ron Wevers
Paul N. Span
Arend Heerschap
William P. J. Leenders
机构
[1] Radboud university medical center,Department of Radiology and Nuclear Medicine
[2] Radboud Institute for Molecular Life Sciences,Department of Biochemistry
[3] Cancer Center Amsterdam at the Academic Medical Center,Department of Medical Biology
[4] Radboud university medical center,Department of Laboratory Medicine
[5] Radboud university medical center,Department of Radiation Oncology, Radiotherapy and OncoImmunology Laboratory
来源
Cancer & Metabolism | / 7卷
关键词
IDH mutations; Metabolism; EGCG; Radiotherapy; Glutamate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 365 条
[1]  
Parsons DW(2008)An integrated genomic analysis of human glioblastoma multiforme Science. 321 1807-1812
[2]  
Jones S(2007)Genetic pathways to primary and secondary glioblastoma Am J Pathol 170 1445-1453
[3]  
Zhang X(2009)IDH1 and IDH2 mutations in gliomas N Engl J Med 360 765-773
[4]  
Lin JC(2009)Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 1058-1066
[5]  
Leary RJ(2011)IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours J Pathol 224 334-343
[6]  
Angenendt P(2013)Extraskeletal osteosarcoma: a very rare case report of primary tumor of the colon-rectum and review of the literature Pathol Res Pract 209 393-396
[7]  
Ohgaki H(2012)Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping Oncologist. 17 72-79
[8]  
Kleihues P(2014)Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate Oncologist. 19 602-607
[9]  
Yan H(2018)Immunohistochemically detected IDH1(R132H) mutation is rare and mostly heterogeneous in prostate cancer World J Urol 36 877-882
[10]  
Parsons DW(2012)Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation J Biol Chem 287 14615-14620